trial · primary record
bi-4SCAR GD2/CD56 T cells
Malignant Disease
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Number of patients with adverse events. |
| Registry ID | NCT05437328 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:01.764Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05437328
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.